Search Results - "Kane‐Gill, Sandra L."

Drug‐Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database by Welch, Hanna K., Kellum, John A., Kane‐Gill, Sandra L.

“…Study Objective Acute kidney injury (AKI) is a common condition associated with both short‐term and long‐term consequences including dialysis, chronic kidney…”
Get full text

Coronavirus Disease 2019 Pandemic Measures: Reports From a National Survey of 9,120 ICU Clinicians by Kleinpell, Ruth, Ferraro, David M., Maves, Ryan C., Kane Gill, Sandra L., Branson, Richard, Greenberg, Steven, Doersam, Jennifer K., Raman, Rameela, Kaplan, Lewis J.

“…IMPORTANCE:Recent reports identify that among hospitalized coronavirus disease 2019 patients, 30% require ICU care. Understanding ICU resource needs remains an…”
Get full text

Innovative Use of Novel Biomarkers to Improve the Safety of Renally Eliminated and Nephrotoxic Medications by Barreto, Erin F., Rule, Andrew D., Voils, Stacy A., Kane‐Gill, Sandra L.

“…Over the last decade, the discovery of novel renal biomarkers and research on their use to improve medication effectiveness and safety has expanded…”
Get full text

Innovations in Medication Safety: Services and Technologies to Enhance the Understanding and Prevention of Adverse Drug Reactions by Kane‐Gill, Sandra L.

Get full text

Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock by Buckley, Mitchell S., Barletta, Jeffrey F., Smithburger, Pamela L., Radosevich, John J., Kane‐Gill, Sandra L.

“…Shock syndromes are associated with unacceptably high rates of mortality in critically ill patients despite advances in therapeutic options. Vasodilatory shock…”
Get full text

Transforming the Medication Regimen Review Process Using Telemedicine to Prevent Adverse Events by Kane‐Gill, Sandra L., Wong, Adrian, Culley, Colleen M., Perera, Subashan, Reynolds, Maureen D., Handler, Steven M., Kellum, John A., Aspinall, Monica B., Pellett, Megan E., Long, Keith E., Nace, David A., Boyce, Richard D.

“…Background/Objectives Federally‐mandated consultant pharmacist‐conducted retrospective medication regimen reviews (MRRs) are designed to improve medication…”
Get full text

An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021 by Li, Xiaotong, Ndungu, Patrick, Taneja, Sanya B., Chapin, Maryann R., Egbert, Susan B., Akenapalli, Krishi, Paine, Mary F., Kane‐Gill, Sandra L., Boyce, Richard D.

“…Kratom is a widely used Asian botanical that has gained popularity in the United States due to a perception that it can treat pain, anxiety, and opioid…”
Get full text

Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid‐related adverse drug reactions in the FDA database over 15 years by Andreaggi, Christian A., Novak, Emily A., Mirabile, Mitchell E., Sampathkumar, Shivani, Gray, Matthew P., He, Meiqi, Kane‐Gill, Sandra L.

“…To perform an in‐depth analysis of opioid‐related ADRs reported by consumers, manufacturers and healthcare professionals. Delving into the depth and breadth of…”
Get full text

Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review by Niznik, Joshua D., He, Harvey, Kane-Gill, Sandra L.

“…Utilization of telemedicine allows pharmacists to extend the reach of clinical interventions, connecting them with patients and providers, but the overall…”
Get full text

Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup by Chawla, Lakhmir S., Bellomo, Rinaldo, Bihorac, Azra, Goldstein, Stuart L., Siew, Edward D., Bagshaw, Sean M., Bittleman, David, Cruz, Dinna, Endre, Zoltan, Fitzgerald, Robert L., Forni, Lui, Kane-Gill, Sandra L., Hoste, Eric, Koyner, Jay, Liu, Kathleen D., Macedo, Etienne, Mehta, Ravindra, Murray, Patrick, Nadim, Mitra, Ostermann, Marlies, Palevsky, Paul M., Pannu, Neesh, Rosner, Mitchell, Wald, Ron, Zarbock, Alexander, Ronco, Claudio, Kellum, John A.

“…Acute kidney injury (AKI) and chronic kidney disease are increasingly recognized as interconnected entities and the term acute kidney disease (AKD) has been…”
Get full text

The effectiveness of intravenous vitamin K in correcting cirrhosis‐associated coagulopathy by Rivosecchi, Ryan M., Kane‐Gill, Sandra L., Garavaglia, Jeffrey, MacLasco, Adam, Johnson, Heather

“…Objectives The goal of this study was to evaluate the effectiveness of intravenous (IV) vitamin K in cirrhosis. Methods This was a retrospective study of…”
Get full text

Risk Factors for Acute Kidney Injury in Older Adults With Critical Illness: A Retrospective Cohort Study by Kane-Gill, Sandra L., PharmD, MSc, Sileanu, Florentina E., BS, Murugan, Raghavan, MD, Trietley, Gregory S., BS, Handler, Steven M., MD, PhD, Kellum, John A., MD

“…Background Risk for acute kidney injury (AKI) in older adults has not been evaluated systematically. We sought to delineate the determinants of risk for AKI in…”
Get full text

Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages by Ammar, Mahmoud A., Sacha, Gretchen L., Welch, Sarah C., Bass, Stephanie N., Kane-Gill, Sandra L., Duggal, Abhijit, Ammar, Abdalla A.

“…The rapid spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a global pandemic. The 2019 coronavirus disease (COVID-19)…”
Get full text

Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin–Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study by Kane-Gill, Sandra L., Ostermann, Marlies, Shi, Jing, Joyce, Emily L., Kellum, John A.

“…Introduction A drug combination that has gained recent attention for an additive risk of nephrotoxicity is vancomycin plus piperacillin–tazobactam. Clinicians…”
Get full text

Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children by Joyce, Emily L, Kane-Gill, Sandra L, Priyanka, Priyanka, Fuhrman, Dana Y, Kellum, John A

“…There continues to be uncertainty about whether piperacillin/tazobactam (TZP) increases the risk of AKI in critically ill pediatric patients. We sought to…”
Get full text

Analysis of risk factors for adverse drug events in critically ill patients by Kane-Gill, Sandra L, Kirisci, Levent, Verrico, Margaret M, Rothschild, Jeffrey M

“…OBJECTIVES:An evaluation of risk factors for adverse drug events in critically ill patients has not been previously studied. The purpose of this original study…”
Get full text

Clinical Practice Guideline: Safe Medication Use in the ICU by Kane-Gill, Sandra L., Dasta, Joseph F., Buckley, Mitchell S., Devabhakthuni, Sandeep, Liu, Michael, Cohen, Henry, George, Elisabeth L., Pohlman, Anne S., Agarwal, Swati, Henneman, Elizabeth A., Bejian, Sharon M., Berenholtz, Sean M., Pepin, Jodie L., Scanlon, Mathew C., Smith, Brian S.

“…To provide ICU clinicians with evidence-based guidance on safe medication use practices for the critically ill. PubMed, Cochrane Database of Systematic…”
Get full text

A Systematic Review of ICU and Non-ICU Clinical Pharmacy Services Using Telepharmacy by Strnad, Kyle, Shoulders, Bethany R., Smithburger, Pamela L., Kane-Gill, Sandra L.

“…Objective: To assess the impact of telepharmacy services in the acute care setting. Data Sources: EMBase, MEDLINE, and SCOPUS database searches were performed…”
Get full text

Drug management in acute kidney disease – Report of the Acute Disease Quality Initiative XVI meeting by Ostermann, Marlies, Chawla, Lakhmir S., Forni, Lui G., Kane‐Gill, Sandra L., Kellum, John A., Koyner, Jay, Murray, Patrick T., Ronco, Claudio, Goldstein, Stuart L.

“…Aims To summarize and extend the main conclusions and recommendations relevant to drug management during acute kidney disease (AKD) as agreed at the 16th Acute…”
Get full text

The Importance of Research and Scholarly Activity in Pharmacy Training by Deal, Eli N., Stranges, Paul M., Maxwell, Whitney D., Bacci, Jennifer, Ashjian, Emily J., DeRemer, David L., Kane-Gill, Sandra L., Norgard, Nicholas B., Dombrowski, Lauren, Parker, Robert B.

“…Regardless of practice setting, it is imperative that pharmacists be able to either participate in generating new knowledge or use the ever‐expanding body of…”
Get full text